Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma

被引:0
作者
Rui Zhang
Qi Li
Jialu Fu
Zhechuan Jin
Jingbo Su
Jian Zhang
Chen Chen
Zhimin Geng
Dong Zhang
机构
[1] The First Affiliated Hospital of Xi’an Jiaotong University,Department of Hepatobiliary Surgery
来源
BMC Cancer | / 21卷
关键词
Genomic mutation signature; Tumor mutation burden; Intrahepatic cholangiocarcinoma; Prognostic biomarker; Nomogram;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 266 条
[1]  
Banales JM(2020)Cholangiocarcinoma 2020: the next horizon in mechanisms and management Nat Rev Gastroenterol Hepatol 17 557-588
[2]  
Marin JJG(2017)Whole-genome and Epigenomic landscapes of etiologically distinct subtypes of Cholangiocarcinoma Cancer Discov 7 1116-1135
[3]  
Lamarca A(2014)Treatment and prognosis for patients with intrahepatic Cholangiocarcinoma: systematic review and meta-analysis JAMA Surg 149 565-574
[4]  
Rodrigues PM(2017)Performance of prognostic scores and staging systems in predicting long-term survival outcomes after surgery for intrahepatic cholangiocarcinoma J Surg Oncol 116 1085-1095
[5]  
Khan SA(2016)Intrahepatic cholangiocarcinoma: epidemiology, risk factors, diagnosis and surgical management Cancer Lett 379 198-205
[6]  
Roberts LR(2015)Intrahepatic cholangiocarcinoma: expert consensus statement HPB (Oxford) 17 669-680
[7]  
Cardinale V(2018)Cholangiocarcinoma - evolving concepts and therapeutic strategies Nat Rev Clin Oncol 15 95-111
[8]  
Carpino G(2018)Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence BMC Gastroenterol 18 180-243
[9]  
Andersen JB(2016)Management and outcomes of patients with recurrent intrahepatic Cholangiocarcinoma following previous curative-intent surgical resection Ann Surg Oncol 23 235-856
[10]  
Braconi C(2018)Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent Br J Surg 105 848-511